ANNEX 1 27 LIABILITIES In thousands of euros Note 12/31/17 12/31/16 Shareholders’ equity 6 Share capital 606 485 Premiums related to the share capital 112,140 91,230 Legal reserve — — Restricted reserves 174 174 Retained earnings (38,537) (21,139) Net loss (19,045) (17,398) Total Shareholders’ equity 55,339 53,353 Provisions for liabilities and charges: Provisions for liabilities 52 — Total provisions for liabilities and charges 52 — Liabilities 7 Refundable advances 3,033 2,957 Trade payables 2,440 1,734 Tax and social liabilities 1,838 1,120 Other liabilities 9 7 Deferred income 10 — — Total liabilities 7,320 5,818 Regularisation accounts Foreign exchange differences – liabilities 3 1 TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY 62,714 59,172 The attached note forms an integral part of the financial statements. GENSIGHT BIOLOGICS – 2017 Registration Document –245